Pemafibrate-based Solutions for Diverse Industries

The present inventive concept expands the applications of pemafibrate, a salt thereof, or a solvate of any of these, to novel industries and use cases, leveraging its PPARα activity to address pressing problems in agriculture, environmental sustainability, bioremediation, energy, and building management.

The original patent disclosed pemafibrate dosing regimens for treating dyslipidemia. However, its potential applications were limited to the pharmaceutical industry. The present inventive concept addresses this limitation by exploring pemafibrate's utility in entirely new fields, thereby unlocking its full potential.

The new inventive concept encompasses four primary applications: (1) agricultural pest control, where pemafibrate is combined with an OATP1B inhibitor to prevent pest infestation; (2) environmental pollutant reduction, where pemafibrate is administered to waste treatment systems to monitor pollutant reduction; (3) bioremediation of contaminated soil, where pemafibrate enhances microorganism-mediated pollutant degradation; and (4) energy efficiency improvement, where pemafibrate is used to optimize energy usage in buildings and enhance solar panel performance.

The new claims introduce unprecedented applications of pemafibrate, deviating significantly from the original patent's focus on dyslipidemia treatment. The inventive step lies in recognizing pemafibrate's PPARα activity as a valuable asset for addressing diverse industrial challenges.

Other potential embodiments of the inventive concept could involve pemafibrate-based solutions for water treatment, textile manufacturing, or cosmetics. Additionally, pemafibrate could be combined with other compounds or used in different formulations to enhance its effectiveness in these new applications.

The pemafibrate-based solutions have vast commercial potential, targeting industries such as agriculture, environmental sustainability, energy, and construction. The market size for these applications is substantial, with opportunities for partnerships, licensing, and direct sales.